344 results on '"Thomas Réjean"'
Search Results
2. The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002-2020).
3. T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers
4. Population‐level effectiveness of pre‐exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data
5. Effect of autogenic training on quality of life and symptoms in people living with HIV: A mixed method randomized controlled trial
6. A longitudinal view of successful aging with HIV: role of resilience and environmental factors
7. Past dynamics of HIV transmission among men who have sex with men in Montréal, Canada: a mathematical modeling study
8. The process of learning the autogenic training relaxation technique and its benefits on the wellness of people living with HIV
9. Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022.
10. Past dynamics of HIV transmission among men who have sex with men in Montreal, Canada: a mathematical modeling study
11. Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montréal, Canada (2013-2020)
12. Relationships between cognition, function, and quality of life among HIV+ Canadian men
13. IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV.
14. Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in Canada
15. Conceptions of sexual health by gay men living with HIV in serodifferent couples in Montreal, Canada: results from a qualitative analysis.
16. Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada
17. Pre-exposure prophylaxis uptake among men who have sex with men who used non-occupational post-exposure prophylaxis: a longitudinal analysis of attendees at a large sexual health clinic in Montréal (Canada)
18. Effectiveness of a Web-Based Intervention to Support Medication Adherence Among People Living With HIV: Web-Based Randomized Controlled Trial
19. Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV
20. Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (Canada)
21. Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV
22. Baseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV.
23. Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in Canada
24. Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs
25. An analysis of socio-demographic and behavioural factors among immigrant MSM in Montreal from an HIV-testing site sample
26. Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis
27. CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy (ART) Regimens: Results From the Quebec Human Immunodeficiency Virus (HIV) Cohort Study
28. Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure.
29. Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak
30. Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)
31. Effect of autogenic training on quality of life and symptoms in people living with HIV: A mixed method randomized controlled trial
32. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection
33. Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study
34. Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
35. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
36. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
37. CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy Regimens: Results From the Quebec Human Immunodeficiency Virus Cohort Study.
38. Association Between the Development of Subclinical Cardiovascular Disease and Human Immunodeficiency Virus (HIV) Reservoir Markers in People With HIV on Suppressive Antiretroviral Therapy.
39. Factors partitioning physical frailty in people aging with HIV: A classification and regression tree approach
40. High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection
41. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l’Actuel PrEP Cohort (2013–2020)
42. Effect of Autogenic Training on Quality of Life and Symptoms in HIV: A Mixed Method Wait-List Randomized Controlled Trial
43. Moments of Uncertainty: Exploring How an App-Based Oral HIV Self-Testing Strategy Fits in Communities ‘Living Under’ HIV Risk
44. Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)
45. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
46. Human Immunodeficiency Virus (HIV)-Specific Effector CD8 T Cell Activity in Patients with Primary HIV Infection
47. Characteristics of new HIV diagnoses over 1995–2019: A clinic-based study in Montréal, Canada
48. Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015
49. Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance
50. Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.